Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,135,581 papers from all fields of science
Search
Sign In
Create Free Account
SLC38A1 gene
Known as:
SLC38A1
, AMINO ACID TRANSPORTER SYSTEM A, MEMBER 1
, NAT2
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
SLC38A5 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Genetic variants of N-acetyltransferases 1 and 2 (NAT1 and NAT2) in cynomolgus and rhesus macaques.
Y. Uno
,
N. Murayama
,
H. Yamazaki
Biochemical Pharmacology
2020
Corpus ID: 216593135
2017
2017
Antithyroglobulin Antibody as a Marker of Successful Ablation Therapy in Differentiated Thyroid Cancer
A. R. Dewi
,
B. Darmawan
,
Achmad Hussein Sundawa Kartamihadja
,
Basuki Hidayat
,
J. Masjhur
World Journal of Nuclear Medicine
2017
Corpus ID: 14261269
The aim of this study was to determine the role of antithyroglobulin antibody (ATA) serum as a marker of successful I-131…
Expand
2014
2014
[Effect of Tibetan medicine zuotai on the activity, protein and mRNA expression of CYP1A2 and NAT2].
Xiang-yang Li
,
Yong-nian Liu
,
+7 authors
Yue Yin
Yao xue xue bao = Acta pharmaceutica Sinica
2014
Corpus ID: 7681959
To study the effect of Tibetan medicine Zuotai on the activity, protein and mRNA expression of CYP1A2 and NAT2, three different…
Expand
2012
2012
Prevalence of fibromyalgia in the Israeli population: a population-based study to estimate the prevalence of fibromyalgia in the Israeli population using the London Fibromyalgia Epidemiology Study…
S. Sun
,
K. Fang
,
Yan Zhao
,
Xinfeng Yan
,
X. Chang
2012
Corpus ID: 220763258
OBJECTIVES Evidence indicates that the hyperplasia and inflammation of synovial tissues are significantly related to the…
Expand
2007
2007
Analysis of NAT2 point mutations with biological microchips
Zh. M. Kozhekbaeva
,
A. Glotov
,
+10 authors
T. V. Nasedkina
Molecular Biology
2007
Corpus ID: 20517354
The NAT2 product, N-acetyltransferase 2, is involved in biotransformation and detoxification of several aromatic amines (in…
Expand
2005
2005
Placental System A Transporter mRNA is Not Different in Preeclampsia, Normal Pregnancy, or Pregnancies with Small-for-Gestational-Age Infants
A. Malina
,
A. Daftary
,
W. Crombleholme
,
N. Marković
,
J. Roberts
Hypertension in Pregnancy
2005
Corpus ID: 12454527
Objective: System A amino acid transporter activity is reduced in placentas from small-for-gestational-age (SGA) compared to…
Expand
2001
2001
Differential influence of cAMP on the expression of the three subtypes (ATA1, ATA2, and ATA3) of the amino acid transport system A
T. Hatanaka
,
Wei Huang
,
R. Martindale
,
V. Ganapathy
FEBS Letters
2001
Corpus ID: 38232348
2000
2000
Novel allele containing a 190C>T nonsynonymous substitution in the N‐acetyltransferase (NAT2) gene
K. Shishikura
,
H. Hohjoh
,
K. Tokunaga
Human Mutation
2000
Corpus ID: 29188357
N‐acetyltransferase (NAT2) is an enzyme involved in detoxification of various carcinogens. The gene is highly polymorphic with a…
Expand
1999
1999
[Biochemical, molecular genetic and ecogenetic studies of polymorphic arylamine N-acetyltransferase (NAT2) in the brain].
M. Ogawa
Fukuoka igaku zasshi = Hukuoka acta medica
1999
Corpus ID: 43468481
Polymorphic arylamine N-acetyltransferase (NAT2) is a detoxification enzyme in the liver. The activity of this enzyme differs for…
Expand
1997
1997
Study of the role of the highly conserved residues Arg9 and Arg64 in the catalytic function of human N-acetyltransferases NAT1 and NAT2 by site-directed mutagenesis.
Claudine Deloménie
,
G. Goodfellow
,
Rajagopal Krishnamoorthy
,
Denis M. Grant
,
J. Dupret
Biochemical Journal
1997
Corpus ID: 23812587
The arylamine N-acetyltransferases (NATs) NAT1 and NAT2 are responsible for the biotransformation of many arylamine and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE